Percutaneous electrolysis versus laser for supraspinatus tendon pain
Official title: Efficacy of Therapeutic Percutaneous Electrolysis Simple vs Therapeutic Percutaneous Electrolysis Multifiliar Therapy in Supraspinatus Tendinopathy. Randomized Clinical Trial.
Run by Universidad Pontificia de Salamanca · NCT07247825 · Data updated 2026-11-12
This study will test whether percutaneous electrolysis or laser therapy better reduces pain and improves shoulder function in adults with supraspinatus tendinopathy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Universidad Pontificia de Salamanca Academic / other |
| Locations | 1 site (Salamanca) |
| Status | Recruiting |
| Started | January 10, 2026 |
| Main results expected | June 1, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT07247825 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with at least four weeks of shoulder symptoms, a pain score of 3 or higher, limited range of motion, positive supraspinatus palpation, and ultrasound confirmation of rotator cuff tendinopathy are ideal candidates.
✕Probably not a fit
People with other acute or chronic musculoskeletal conditions or neuropathic pain that could confound results, or those who cannot receive invasive physiotherapy techniques, are unlikely to benefit from the interventions tested here.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-blind randomized trial enrolling patients from the ValleSur physiotherapy clinic in Ávila with ultrasound-confirmed supraspinatus tendinopathy. Eligible participants will be diagnosed by an orthopaedic surgeon and undergo ultrasound to identify the treatment target before random assignment to percutaneous electrolysis or laser therapy. Outcomes will include pain intensity, shoulder range of motion, and quality of life measured at baseline and after the treatment course. The protocol focuses on pragmatic, clinic-based delivery of the two interventions and blinded outcome assessment where possible.
Why it matters
Potential benefit: If successful, the trial could identify a more effective non-surgical treatment to reduce pain and improve function for people with supraspinatus tendinopathy.
How similar studies have gone: Smaller trials and case series have reported benefits for both therapeutic electrolysis and laser in tendinopathies, but high-quality head-to-head randomized evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signing of informed consent both to participate in the study and to undergo invasive physiotherapy techniques. * Presence of symptoms (inflammation or pain) ≥ 4 weeks. * Positive palpation test of the supraspinatus tendon. * Men and women over 18 years of age. * Score of 3 or higher on the shoulder pain analogue scale. * Adequate cognitive ability for understanding. * Limited range of motion. * Rotator cuff tendinopathy confirmed by ultrasound at the study centre, either due to tendon inflammation, presence of hypoechoic areas, calcification, fibrillar disorganisation and/or neovascularisation in the supraspinatus muscle. * Pain in the proximal lateral part of the arm that worsens with abduction. Exclusion Criteria: * Any related acute or chronic musculoskeletal disease that may affect the results of the study. * Presence of neuropathic pain such as lumbar radiculopathy, which may affect the results of the study. * Not receiving the treatment sessions and assessments of the study. * History of glenohumeral fracture and rheumatoid arthritis. * Rheumatic, neurological or structural polymyalgia affecting the joint. * Pregnancy. * Patients with cardiovascular disease. * Patients with neurological disease. * Local infection. * Tumours. * Belonephobia. * Taking anticoagulants or antiplatelet agents. * Infiltrative and/or rehabilitative treatment in the two months prior to recruitment. * Treatment with another intervention during the study.
Where it's running
-
Universidad Pontificia de Salamanca
Salamanca, Spain Recruiting
Study contacts
- Study coordinator: Jorge V Velázquez Saornil, PhD.
- Email: jvelazquezsa@upsa.es
- Phone: 920277000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyaluronic Acid vs Platelet-R-rich Plasma for Chronic Tendinopathy and Enthesopathy
This study tests whether injections of hyaluronic acid or autologous platelet-rich plasma can help people with chronic tendon and enthesis problems in the elbow or Achilles area.
-
Vibration or cool-spray to reduce pain from steroid injections in the hand and wrist
This trial tests whether vibration or vapocoolant spray makes corticosteroid injections in the hands, wrists, or elbows less painful for adults with arthritis, tendinopathy, or nerve compression.
-
Platelet-rich plasma injections for joint and tendon problems
This project will test whether platelet-rich plasma (PRP) injections help people with osteoarthritis and other musculoskeletal conditions reduce pain and improve function over one year.
-
Comparing exercise programs for long head biceps tendinopathy
We will try 12 weeks of eccentric or combined exercise programs versus a control exercise to see if they reduce shoulder pain and tendon thickness in people with long head biceps tendinopathy.
-
Using OSTENIL® TENDON to treat pain and mobility issues in tendon disorders
This study is testing if OSTENIL® TENDON can help people with tendon pain and mobility issues feel better in everyday life.
-
Using advanced ultrasound to track blood flow in healthy and injured tendons
This study is testing a new ultrasound method to see if it can help spot differences in blood flow in healthy and injured tendons, specifically for people with overuse injuries like Achilles and patellar tendinopathy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.